Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?

Back

ESC Professional Premium Access

Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?

Session: Statin therapy: clinical role and current challenges

Topic: Lipid-Lowering Agents

Speaker: Doctor D. Cosmi (Perugia, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Deborah Cosmi

Gubbio-Gualdo Tadino Hospital, Perugia (Italy)

0 follower

5 more presentations in this session

Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data

Speaker: Doctor M. Abdelghani (Doha, QA)

Access

Abstract

Slides

The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients

Speaker: Doctor A. Halili (Copenhagen, DK)

Access

Abstract

Slides

Statin use and cardiovascular outcomes after myocardial infarction: a population-based case-control study

Speaker: Doctor V. Kyto (Turku, FI)

Access

Abstract

Slides

Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Access

Abstract

Slides

Use of statins in cancer patients following acute myocardial infarction and its impact on long-term clinical outcomes.

Speaker: Doctor K. Stepien (Krakow, PL)

Access

Abstract

Slides

Access the full session

Statin therapy: clinical role and current challenges

Speakers: Doctor D. Cosmi, Doctor M. Abdelghani, Doctor A. Halili, Doctor V. Kyto, Doctor R. Wijesurendra...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources